RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation
American Journal of Physiology-Cell Physiology · 01.02.2024 · 326 (2) · C331-C347
DOI: 10.1152/ajpcell.00467.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.02.2024. Verfasst von Jinjin Hao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Shaoxing People's Hospital, Shaoxing, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Triterpenes, Diabetes Mellitus. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Object of Training High-level Innovative Health Talents in Zhejiang Province.
Abstract (Originalsprache)
We demonstrated first that the nuclear factor erythroid 2-related factor 2 (Nrf2) activator RTA 408 has a protective effect against diabetic cardiomyopathy. We found that RTA 408 could stimulate the nuclear entry of Nrf2 protein, regulate the mitochondrial fission-fusion balance, and redistribute p65, which significantly alleviated the oxidative stress level in cardiomyocytes, thereby reducing apoptosis and inflammation, and protecting the systolic and diastolic functions of the heart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Shaoxing People's Hospital, Shaoxing, China.
- College of Medicine, Shaoxing University, Shaoxing, China.
- Zhejiang University School of Medicine, Hangzhou, China.
- Zhejiang Chinese Medical University, Hangzhou, China.
- The Affiliated Lihuili Hospital of Ningbo University, Ningbo, China.
- Department of Cardiology, Zhuji People's Hospital, Shaoxing, China.
ORCID-Profile: Hui Lin, Jufang Chi, Dajun Lou
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Object of Training High-level Innovative Health Talents in Zhejiang Province
Zitieren
APA
Hao, J., Zhou, J., Hu, S., Zhang, P., Wu, H., Yang, J., Zhao, B., Liu, H., Lin, H., Chi, J., & Lou, D. (2024). RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation. American Journal of Physiology-Cell Physiology, 326(2), C331-C347. https://doi.org/10.1152/ajpcell.00467.2023
Vancouver
Hao J, Zhou J, Hu S, Zhang P, Wu H, Yang J, et al. RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation. American Journal of Physiology-Cell Physiology. 2024;326(2):C331-C347. doi:10.1152/ajpcell.00467.2023
BibTeX
@article{Hao2024,
author = {Hao, Jinjin and Zhou, Jiedong and Hu, Songqing and Zhang, Peipei and Wu, Haowei and Yang, Juntao and Zhao, Bingjie and Liu, Hanxuan and Lin, Hui and Chi, Jufang and Lou, Dajun},
title = {RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-κB-mediated inflammation},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
volume = {326},
number = {2},
pages = {C331--C347},
doi = {10.1152/ajpcell.00467.2023}
}
EUVIMED